Filter:

Search Results

Fierce's coverage of the Martin Shkreli saga

brighter: Lawmakers filing bills and holding hearings, presidential candidates devising anti-price-hike ...

Novo scores a game-changing diabetes approval, reversing an embarrassing rejection

as safety concerns forced it to delay an FDA filing for its candidate, but the company has vowed to find ...

Sources: Sanofi's Brandicourt looks at spinoff of animal health, selling supplement biz

vaccines operation, it will have 5 units going forward, unless one of those gets spun off.- read ...

Perrigo brings Mylan takeover feud to Israeli court

Mylan ($MYL) and its hostile takeover target, Perrigo ($PRGO), have been trading lawsuits in the U.S., but now they've taken their legal battle across the ocean. Thursday, Perrigo filed a suit against Mylan in Israeli Court alleging that its pursuer failed to publish a lawful tender offer in Israel ...

In latest biopharma-med tech pairing, Teva snaps up respiratory compliance tracker Gecko

in wearable and ingestible technology, while Otsuka and Proteus filed with the FDA for the first approval ...

Shire chalks up victory in Vyvanse patent battle

itching to launch copycat versions of the med, prompting Shire to file a string of patent infringement ...

Troubled GlaxoSmithKline to shutter R&D facility in France

in Philadelphia and Cambridge, MA, as it creates a new vaccines R&D hub in Rockville, MD. Related Articles: ...

Alexion sues Canada over Soliris price cut attempt as drug cost debate explodes on center stage

filings that the Canadian agency does not have the authority to force it to lower its price on its drug. ...

What do multinational drug firms want from Xi-Obama summit?

medicines." In April, Pfizer shut its vaccines operation in China, citing a failure to get regulatory approval ...

Aduro adds checkpoint inhibitors to a 'breakthrough' mix in $32M buyout

mesothelin to spur a targeted attack on cancer cells. That drug has been added to the cancer vaccine GVAX, ...